NCT02131948View on ClinicalTrials.gov

Regulation of Endogenous Glucose Production by Brain Insulin Action

PHASE1CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

July 31, 2014

Study Completion Date

July 31, 2014

Conditions
Insulin Resistance, Diabetes
Interventions
DRUG

Intranasal insulin

Intranasal spray

DRUG

Intranasal placebo

Intranasal spray

Trial Locations (1)

M5G 1L7

Tornto General Hospital, UHN, Toronto

All Listed Sponsors
lead

University Health Network, Toronto

OTHER

NCT02131948 - Regulation of Endogenous Glucose Production by Brain Insulin Action | Biotech Hunter | Biotech Hunter